Skip to main content

Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Grawe RW, Falloon IRH, Widen JH, Skogvoll E. Two-years of continued early treatment for recent-onset schizophrenia: a randomised controlled study. Objective: 

This random-controlled study evaluated benefits derived from continued integrated biomedical and psychosocial treatment for recent-onset schizophrenia. Method: 

Fifty cases of schizophrenia of less than 2 years duration were allocated randomly to integrated or standard treatment (ST) for 2 years. ST comprised optimal pharmacotherapy and case management, while IT also included cognitive-behavioural family treatment, that incorporated skills training, cognitive-behavioural strategies for residual psychotic and non-psychotic problems and home-based crisis management. Psychopathology, functioning, hospitalisation and suicidal behaviours were assessed two monthly and a composite index, reflecting overall clinical outcome was derived. Results: 

IC proved superior to ST in reducing negative symptoms, minor psychotic episodes and in stabilising positive symptoms, but did not reduce hospital admissions or major psychotic recurrences. The composite index showed that significantly more IC patients (53%) had excellent 2-year outcomes than ST (25%). Conclusion: 

Evidence-based treatment achieves greater clinical benefits than pharmacotherapy and case management alone for recent-onset schizophrenia.

Keywords: clinical outcome; early intervention; randomised controlled trial; schizophrenia

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1600-0447.2006.00799.x

Affiliations: 1: SINTEF Health Research, Trondheim, Norway 2: Telemark Hospital, Norway 3: Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway

Publication date: 2006-11-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more